Page 441 - Si Reporter

Zomato rallies 5%, hits 2-year high on healthy December quarter results

The growth was fueled by Blinkit, which rose 27 per cent Q-o-Q, while food delivery revenue grew 10 per cent Q-o-Q

Mid, small-caps nurse losses as benchmarks stay rangebound; PSU stocks sink

Stock market highlights on February 9, 2024: Among sectors, the Nifty Metal index declined 1.5 per cent, followed by the Nifty Auto, and IT indices (0.4 per cent each)

Escorts Kubota plunges 10%, hits 5-month low on disappointing Q3 results

The company expects a 6-7 per cent volume decline for the overall tractor industry in FY24 and a weak Q1FY25 if elections are declared during the said period.

RBI policy, selling in ITC drag Sensex 724 pts, Nifty near 21,700

Stock market highlights on February 8, 2024: The Nifty PSU bank index climbed 2 per cent, while the Nifty Private Bank index fell 2.5 per cent. Individually, Paytm, and ITC crashed up to 10 per cent

Trent rallies 27% in two days, hits new high on stellar Q3 results

The brokerage firm Motilal Oswal Financial Services has reiterated a 'buy' rating on the stock with a target price of Rs 4,200.

Lupin soars 7%, trades at highest level since Aug 2016 on strong Q3 results

The company's profit jumped nearly 300 per cent to Rs 613 crore for the December 2023 quarter from a year ago period.

Benchmarks end flat, MidCap index rises 1.5%; PSB, realty stocks in demand

Stock market highlights on February 7, 2024: In the broader markets, the BSE MidCap index gained over 1.48 per cent, while the BSE SmallCap index advanced 0.35 per cent

YES Bank hits highest level since June 2020; stock zooms 28% in 2 days

Till 03:05 pm, a combined 1,524 million equity shares, representing 5 per cent of total equity of YES Bank, had changed hands on the NSE and BSE

SBI rallies 3%, hits all-time high on positive medium-term outlook

SBI news: Among PSU banks, SBI has a healthy provision coverage ratio (PCR), adequate capitalisation, a strong liability franchise, and an improving asset quality outlook

Sensex surges 455 pts, Nifty tops 21,900; IT index jumps 3%, YES Bank 12%

Stock market highlights on February 6, 2024: The Nifty Auto, Metal, and Pharma added over 1 per cent each

Paytm rebounds 19% from record low amid heavy volumes

The stock hit a new low at Rs 395.50 in intra-day deals on Tuesday, and then rebounded into the positive zone for the first time in last four trading days.

BLS E-Services makes robust debut; zooms 140% over its issue price

The Rs 311 crore Initial Public Offer (IPO) of BLS E-Services had received a whopping 162.38 times subscription.

Sensex drops 354 pts in fag-end, Nifty below 21,800; RIL, Airtel weigh

Stock market highlights on February 5: Among sectors, the Nifty Pharma, and Auto indices rallied over 1 per cent each

Sensex rallies 440 pts day after interim Budget, Nifty tops 21,850; PSEs up

Stock market highlights on Friday, February 02: In the broader markets, the BSE MidCap index gained 0.8 per cent, while the BSE SmallCap index added 0.5 per cent

Gokaldas Exports to acquire Matrix Clothing's apparel biz; stock zooms 9%

The management is expecting a positive momentum for in the calendar year 2024 and expects sequential growth to pick up over the next quarters

Stocks to watch on Feb 2: Indian Hotels, Hero Moto, Eicher, NMDC, RITES

Stocks to watch on February 2, 2024: Rites' consolidated profit in Q3 fell 12 per cent to Rs 129 crore from last year

Sensex ends Interim Budget session 107 pts down; PSBs shine, Paytm dips 20%

The Nifty ended below 21,700, down 28 points. Maruti, Power Grid, Axis Bank and SBI were the top Sensex 30 gainers, while L&T shed 2 per cent on Thursday. Rail stocks slipped on profit-taking.

ITDC zooms 20% as govt spells support for states to develop tourist centres

The Centre will provide long-term interest free loans to states to encourage the development of tourist centers, the FM said

Aurobindo Pharma sinks 10% as formulation unit undergoes US FDA inspection

The inspection is under progress from January 22, 2024 and has not been concluded yet. Eugia Pharma is the company's injectables arm

Godrej Consumer Products soars 12%, hits new high on Ebitda beat in Q3

Analysts believe the execution machinery being put in place by GCPL is yielding good results with improvement seen in underlying metrics alongside higher cash-generation